Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,536 papers from all fields of science
Search
Sign In
Create Free Account
YH 439
Known as:
YH-439
, YH439
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Thiazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Nucleotide specificity of DNA binding of the aryl hydrocarbon receptor:ARNT complex is unaffected by ligand structure.
D. DeGroot
,
M. Denison
Toxicological Sciences
2014
Corpus ID: 18708662
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxic and biological effects of…
Expand
2010
2010
Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
F. Whelan
,
Nan Hao
,
S. Furness
,
M. Whitelaw
,
A. Chapman-Smith
Molecular Pharmacology
2010
Corpus ID: 18142399
The aryl hydrocarbon receptor (AhR) is traditionally defined as a transcription factor activated by exogenous polyaromatic and…
Expand
2010
2010
Thermal reversible microemulsion system for poorly water-soluble YH439 for oral delivery.
D. Han
,
Zhe-Hu Jin
,
Yan Jin
,
Xue-zhe Yin
,
Yuanyuan Shen
,
Zhong-gao Gao
Chemical and pharmaceutical bulletin
2010
Corpus ID: 29275977
To improve bioavailability of poorly water-soluble YH439, a thermal reversible microemulsion system was prepared using modified…
Expand
1999
1999
Inhibitory effects of isopropyl-2-(1,3-dithietane-2-ylidene)-2- [N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439) on benzo[a]pyrene-induced skin carcinogenesis and micronucleated reticulocyte…
Y. Surh
,
S. G. Kim
,
A. Liem
,
J. Lee
,
J. Miller
Mutation research
1999
Corpus ID: 24497559
1998
1998
Species differences in pharmacokinetics of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits, and dogs.
W. Yoon
,
J. Yoo
,
J. Lee
,
C. Shim
,
M. G. Lee
Drug Metabolism And Disposition
1998
Corpus ID: 1107580
Pharmacokinetic parameters of YH439 and its metabolites, M4, M5, and M7, were compared after iv administration of YH439 to rats…
Expand
1996
1996
Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
I. J. Lee
,
K. Jeong
,
+4 authors
B. Song
Molecular Pharmacology
1996
Corpus ID: 22586131
The molecular mechanism of induction of cytochromes P4501A1/2 (CYP1A1/2) by a synthetic compound YH439 was studied in rodents as…
Expand
1996
1996
Transcriptional inhibition of cytochrome P4502E1 by a synthetic compound, YH439.
K. Jeong
,
I. J. Lee
,
+4 authors
B. Song
Archives of Biochemistry and Biophysics
1996
Corpus ID: 25772794
The molecular mechanism of cytochrome P4502E1 (CYP2E1) inhibition by a synthetic compound, YH439, was studied. In rats treated…
Expand
1996
1996
Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent.
Y. Surh
,
M. Shlyankevich
,
J. Lee
,
J. Yoo
Mutation research
1996
Corpus ID: 32519571
1996
1996
Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
S. H. Kim
,
K. Park
,
W. Yoon
,
J. Lee
,
N. D. Kim
,
M. G. Lee
Research Communications in Molecular Pathology…
1996
Corpus ID: 25278548
The effect of YH-439 pretreatment on the pharmacokinetics of furosemide and azosemide was investigated after intravenous (iv…
Expand
1996
1996
Suppression of rat hepatic cytochrome P450 2E1 expression by isopropyl 2-(1,3-dithioetane-2-ylidene)-2-[N-(4-methyl-thiazol-2-yl)carbamoyl] acetate (YH439), an experimental hepatoprotectant…
E. Choi
,
S. G. Kim
,
J. Lee
,
J. Yoo
,
J. K. Shin
,
N. D. Kim
Biochemical Pharmacology
1996
Corpus ID: 19651711
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE